PLD

107.1

+1.84%↑

DLR

172.24

-0.26%↓

CCI

105

-2%↓

CSGP

96.51

-0.26%↓

WY

25.8

+2.14%↑

PLD

107.1

+1.84%↑

DLR

172.24

-0.26%↓

CCI

105

-2%↓

CSGP

96.51

-0.26%↓

WY

25.8

+2.14%↑

PLD

107.1

+1.84%↑

DLR

172.24

-0.26%↓

CCI

105

-2%↓

CSGP

96.51

-0.26%↓

WY

25.8

+2.14%↑

PLD

107.1

+1.84%↑

DLR

172.24

-0.26%↓

CCI

105

-2%↓

CSGP

96.51

-0.26%↓

WY

25.8

+2.14%↑

PLD

107.1

+1.84%↑

DLR

172.24

-0.26%↓

CCI

105

-2%↓

CSGP

96.51

-0.26%↓

WY

25.8

+2.14%↑

Search

Veris Residential Inc

Avatud

SektorKinnisvara

14.28 1.56

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

13.88

Max

14.28

Põhinäitajad

By Trading Economics

Sissetulek

40M

26M

Müük

8.2M

76M

Aktsiakasum

-0.12

Dividenditootlus

2.11

Kasumimarginaal

34.805

Töötajad

188

EBITDA

-20M

9.6M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+31.5% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

2.11%

6.00%

Järgmine tulemuste avaldamine

29. okt 2025

Järgmine dividendimakse kuupäev

15. okt 2025

Järgmine aktsia dividendi kuupäev (ex-date)

29. sept 2025

Turustatistika

By TradingEconomics

Turukapital

1.4M

1.6B

Eelmine avamishind

12.72

Eelmine sulgemishind

14.28

Uudiste sentiment

By Acuity

50%

50%

66 / 189 Pingereas Real estate

Veris Residential Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

4. aug 2025, 21:42 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

4. aug 2025, 21:21 UTC

Tulu
Suurimad hinnamuutused turgudel

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

4. aug 2025, 20:45 UTC

Tulu

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

4. aug 2025, 19:15 UTC

Suurimad hinnamuutused turgudel

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

4. aug 2025, 23:41 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4. aug 2025, 23:41 UTC

Market Talk

Nikkei May Rise on Fed Stimulus Hopes

4. aug 2025, 23:28 UTC

Market Talk

Global Equities Roundup: Market Talk

4. aug 2025, 23:28 UTC

Market Talk

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

4. aug 2025, 21:30 UTC

Tulu

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4. aug 2025, 21:21 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

4. aug 2025, 21:18 UTC

Tulu

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4. aug 2025, 20:25 UTC

Market Talk

India Hits Back Over Russian Oil Purchases -- Market Talk

4. aug 2025, 20:25 UTC

Tulu

Transocean 2Q Loss $938M >RIG

4. aug 2025, 20:25 UTC

Tulu

Transocean 2Q Loss/Shr $1.06 >RIG

4. aug 2025, 20:18 UTC

Tulu

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

4. aug 2025, 20:15 UTC

Tulu

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

4. aug 2025, 20:14 UTC

Tulu

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

4. aug 2025, 20:14 UTC

Tulu

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

4. aug 2025, 20:14 UTC

Tulu

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

4. aug 2025, 20:13 UTC

Tulu

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

4. aug 2025, 20:09 UTC

Tulu

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

4. aug 2025, 20:06 UTC

Tulu

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

4. aug 2025, 20:01 UTC

Tulu

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

4. aug 2025, 20:01 UTC

Tulu

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

4. aug 2025, 20:01 UTC

Tulu

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

4. aug 2025, 20:01 UTC

Tulu

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

4. aug 2025, 19:41 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

4. aug 2025, 19:28 UTC

Market Talk

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

4. aug 2025, 19:07 UTC

Market Talk

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

4. aug 2025, 18:27 UTC

Market Talk

Gold Climbs on Rate Cut Speculation -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Veris Residential Inc Prognoos

Hinnasiht

By TipRanks

31.5% tõus

12 kuu keskmine prognoos

Keskmine 18.2 USD  31.5%

Kõrge 22 USD

Madal 15 USD

Põhineb 5 Wall Streeti analüütiku instrumendi Veris Residential Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

5 ratings

2

Osta

3

Hoia

0

Müü

Sentiment

By Acuity

66 / 189 Pingereas Kinnisvara

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Keskmine

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Veris Residential Inc

Veris Residential, Inc. is a forward-thinking, environmentally and socially conscious real estate investment trust (REIT) that primarily owns, operates, acquires and develops holistically-inspired, Class A multifamily properties that meet the sustainability-conscious lifestyle needs of today's residents while seeking to positively impact the communities it serves and the planet at large. The company is guided by an experienced management team and Board of Directors and is underpinned by leading corporate governance principle; a best-in-class and sustainable approach to operations; and an inclusive culture based on equality and meritocratic empowerment.